ARCHIVES

Demonstration project to yield useful data, Peter Bach says.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

Patient Harm—Including One Death—Cited As Faculty Challenges MD Anderson Leadership

September 20, 2013

Colorado Researchers Study Massage To Reduce Symptoms

September 26, 2003

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

September 26, 1997

NIH Inquiry Finds No Impropriety In Treatment of Teddy DeVita

April 9, 1976

Research Integrity: Collins’ Student Falsified Data, ORI Finds

August 22, 1997